Related Experiment Videos
Immunosuppressive treatment of multiple sclerosis
Journal of Neurosurgical Nursing
|August 1, 1985
Summary
Multiple sclerosis (MS), a common neurologic disease, may benefit from cyclophosphamide treatment. This article explores immunosuppressive therapy for MS and outlines essential nursing care for clinical trials.
Area of Science:
- Neurology
- Immunology
- Clinical Nursing
Background:
- Multiple sclerosis (MS) is a prevalent chronic neurologic disease in adults.
- The precise pathogenesis of MS remains unknown, but it is widely considered an autoimmune disorder.
- Emerging evidence suggests potential therapeutic benefits of cyclophosphamide in managing MS.
Purpose of the Study:
- To discuss the rationale behind using immunosuppressive therapy for multiple sclerosis.
- To identify critical nursing interventions for patients participating in clinical trials involving immunosuppressive agents.
Main Methods:
- Literature review on the immunopathogenesis of MS.
- Analysis of recent studies investigating cyclophosphamide efficacy in MS treatment.
- Identification of nursing care standards for immunosuppressive therapy clinical trials.
Main Results:
- Cyclophosphamide shows promise as a treatment for multiple sclerosis.
- Immunosuppressive therapy is a viable approach for MS management.
- Specific nursing measures are crucial for safe and effective clinical trial conduct.
Conclusions:
- Immunosuppressive therapy, particularly with cyclophosphamide, warrants further investigation for multiple sclerosis.
- Careful nursing management is essential to support patients undergoing immunosuppressive treatment in clinical trials.